Qube Research & Technologies (QRT)’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Sell |
83,912
-3,955
| -5% | -$29.9K | ﹤0.01% | 1913 |
|
|
2025
Q1 | $485K | Sell |
87,867
-73,812
| -46% | -$407K | ﹤0.01% | 1979 |
|
|
2024
Q4 | $930K | Buy |
161,679
+40,660
| +34% | +$234K | ﹤0.01% | 1753 |
|
|
2024
Q3 | $1.25M | Buy |
121,019
+61,235
| +102% | +$634K | ﹤0.01% | 1594 |
|
|
2024
Q2 | $775K | Sell |
59,784
-42,841
| -42% | -$556K | ﹤0.01% | 1696 |
|
|
2024
Q1 | $1.79M | Sell |
102,625
-86,203
| -46% | -$1.51M | ﹤0.01% | 1556 |
|
|
2023
Q4 | $1.78M | Buy |
188,828
+75,156
| +66% | +$707K | ﹤0.01% | 1343 |
|
|
2023
Q3 | $1.27M | Buy |
113,672
+68,076
| +149% | +$760K | ﹤0.01% | 1306 |
|
|
2023
Q2 | $976K | Buy |
45,596
+29,942
| +191% | +$641K | ﹤0.01% | 1239 |
|
|
2023
Q1 | $633K | Sell |
15,654
-7,742
| -33% | -$313K | ﹤0.01% | 1412 |
|
|
2022
Q4 | $1.09M | Sell |
23,396
-11,303
| -33% | -$526K | 0.01% | 1122 |
|
|
2022
Q3 | $1.8M | Buy |
34,699
+29,414
| +557% | +$1.53M | 0.01% | 927 |
|
|
2022
Q2 | $250K | Sell |
5,285
-4,018
| -43% | -$190K | ﹤0.01% | 1624 |
|
|
2022
Q1 | $662K | Buy |
9,303
+824
| +10% | +$58.6K | 0.01% | 1373 |
|
|
2021
Q4 | $634K | Buy |
+8,479
| New | +$634K | ﹤0.01% | 1450 |
|
|
2020
Q1 | – | Sell |
-8,096
| Closed | -$500K | – | 1261 |
|
|
2019
Q4 | $500K | Buy |
+8,096
| New | +$500K | 0.02% | 950 |
|